In a bold move, Canada will impose a 25% tariff on US-made vehicles in retaliation against Trump's import taxes. This decision targets non-compliant vehicles under the USMCA, impacting the automotive sector significantly.
Stellantis has paused production at its Canadian and Mexican plants, leading to the temporary layoff of 900 US workers. As tariffs take effect, uncertainty looms over the auto industry and its workforce.
French President Emmanuel Macron has urged European companies to pause their investments in the U.S. following President Trump's controversial global tariffs. This call comes as the EU considers a powerful response to protect its trade interests.
In a surprising Senate vote, four Republican senators joined Democrats to pass a resolution ending Trump's tariffs on Canadian goods, highlighting a growing GOP split on trade issues. This decision raises concerns over job losses and impacts on U.S.-Canada relations.
US President Trump's latest tariffs on UK goods could lead to rising costs for consumers and businesses alike. As the trade war escalates, find out how these changes will affect your wallet and the UK economy.
President Trump's recent announcement of reciprocal tariffs, dubbed 'Liberation Day,' may backfire, causing economic strain for consumers and jeopardizing GOP control in the upcoming midterms.
President Trump's recent tariffs were touted as 'reciprocal', but a closer look reveals a simple and misleading calculation. Experts warn that these measures could have severe consequences for international trade and U.S. companies.
In a surprising move, four Republican senators defied President Trump and voted with Democrats to block his controversial tariffs on Canada. This bipartisan effort raises questions about the future of U.S.-Canada trade relations.
Stellantis is temporarily halting production at assembly plants in Canada and Mexico due to new 25% automotive tariffs imposed by the Trump administration. This shutdown affects thousands of workers and signals significant industry challenges ahead.
In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
